Pharmacies - United States

  • United States
  • The Pharmacies market in the United States is forecasted to achieve a staggering revenue of US$387.30bn by the year 2024.
  • This estimate is based on an anticipated annual growth rate (CAGR 2024-2029) of 3.80%, which would result in a market volume of US$466.70bn by 2029.
  • When comparing global figures, it becomes evident that United States will generate the highest revenue in this market, with an estimated US$387.30bn in 2024.
  • Furthermore, in terms of per capita income, each individual United States is projected to contribute US$1,133.00 in revenue towards the Pharmacies market in 2024.
  • The United States is experiencing a rise in demand for online pharmacies due to convenience and accessibility.

Key regions: United States, China, Germany, Japan, Europe

Region comparison

Analyst Opinion

The Pharmacies market in United States has experienced significant growth in recent years, driven by various factors such as changing customer preferences, emerging trends in the market, local special circumstances, and underlying macroeconomic factors.

Customer preferences:
Customers in the United States have shown a growing preference for pharmacies that offer a wide range of products and services. They value convenience and accessibility, and are increasingly seeking pharmacies that provide not only prescription medications, but also over-the-counter drugs, health and wellness products, and personalized services such as medication therapy management. Additionally, customers are increasingly turning to online pharmacies for their convenience and competitive pricing.

Trends in the market:
One of the key trends in the Pharmacies market in United States is the increasing emphasis on healthcare services. Pharmacies are expanding their offerings beyond just dispensing medications to include services such as immunizations, health screenings, and chronic disease management. This trend is driven by the growing demand for accessible healthcare services and the desire for pharmacies to position themselves as healthcare destinations. Another trend in the market is the rise of specialty pharmacies. These pharmacies focus on providing medications for complex and chronic conditions, such as cancer, HIV/AIDS, and multiple sclerosis. The demand for specialty medications is increasing, and specialty pharmacies are able to provide specialized care and support to patients with these conditions.

Local special circumstances:
The United States has a unique healthcare system, with a significant reliance on private insurance and government programs such as Medicare and Medicaid. This has implications for the Pharmacies market, as the pricing and reimbursement policies of these programs can impact the profitability of pharmacies. Additionally, the presence of pharmacy benefit managers (PBMs) in the United States market has led to increased competition and pressure on pharmacy margins.

Underlying macroeconomic factors:
The United States has a large and aging population, which is driving the demand for healthcare services, including pharmacy services. As the population ages, the prevalence of chronic diseases increases, leading to a higher demand for medications and pharmacy services. Furthermore, the United States has a high per capita healthcare expenditure, which supports the growth of the Pharmacies market. In conclusion, the Pharmacies market in United States is experiencing growth due to changing customer preferences, emerging trends in the market, local special circumstances, and underlying macroeconomic factors. Customers are seeking pharmacies that offer a wide range of products and services, and pharmacies are responding by expanding their offerings and focusing on healthcare services. The unique healthcare system and demographic factors in the United States also contribute to the growth of the market.


Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.


In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.


  • Revenue
  • Users
  • Volume
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait


Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)